The Generics in Belgium industry profile is an essential resource for top-level data and analysis covering the Generics industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation* Provides textual analysis of Generics in Belgium's recent performance and future prospects* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of Generics in Belgium* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by value and/or volume * Five forces scorecards provide an accessible yet in depth view of the market's competitive landscapeWhy you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionFor the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume. All currency conversions were calculated at constant average annual 2009 exchange rates.For the purposes of this report, Europe consists of Western Europe and Eastern Europe.Western Europe comprises Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United Kingdom.Eastern Europe comprises the Czech Republic, Hungary, Poland, Romania, Russia, and Ukraine.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Generics in Belgium
Published on September 2010
Report Summary
The Generics in Belgium industry profile is an essential resource for top-level data and analysis covering the Generics industry. It
includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape,
leading companies and demographic information.
Scope
* Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of Generics in Belgium's recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes a five-year forecast of Generics in Belgium
* The leading companies are profiled with supporting key financial metrics
* Supported by the key macroeconomic and demographic data affecting the market
Highlights
* Detailed information is included on market size, measured by value and/or volume
* Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition
For the purposes of this Profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have
now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered
by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The
market value is evaluated at ex-factory prices. Market volume is quantified here as the percentage of the total ethical pharmaceutical
Generics in Belgium Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not
an absolute measure of market volume. All currency conversions were calculated at constant average annual 2009 exchange rates.
For the purposes of this report, Europe consists of Western Europe and Eastern Europe.
Western Europe comprises Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, and the United
Kingdom.
Eastern Europe comprises the Czech Republic, Hungary, Poland, Romania, Russia, and Ukraine.
Table of Content
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET VOLUME 11
MARKET SEGMENTATION II 12
FIVE FORCES ANALYSIS 13
Summary 13
Buyer power 15
Supplier power 16
New entrants 17
Substitutes 19
Rivalry 20
LEADING COMPANIES 21
Bayer AG 21
Novartis AG 26
Omega Pharma NV 30
Sanofi-Aventis SA 34
MARKET FORECASTS 38
Market value forecast 38
Market volume forecast 39
MACROECONOMIC INDICATORS 40
APPENDIX 42
Methodology 42
Industry associations 43
Related Datamonitor research 43
Disclaimer 44
ABOUT DATAMONITOR 45
Premium Reports 45
Summary Reports 45
Datamonitor consulting 45
Generics in Belgium Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
LIST OF TABLES
Table 1: Belgium generics market value: $ million, 2005'09 10
Table 2: Belgium generics market volume: volume penetration, 2005'09 11
Table 3: Belgium generics market segmentation II: % share, by value, 2009 12
Table 4: Bayer AG: key facts 21
Table 5: Bayer AG: key financials ($) 24
Table 6: Bayer AG: key financials (') 24
Table 7: Bayer AG: key financial ratios 24
Table 8: Novartis AG: key facts 26
Table 9: Novartis AG: key financials ($) 27
Table 10: Novartis AG: key financial ratios 28
Table 11: Omega Pharma NV: key facts 30
Table 12: Omega Pharma NV: key financials ($) 31
Table 13: Omega Pharma NV: key financials (') 32
Table 14: Omega Pharma NV: key financial ratios 32
Table 15: Sanofi-Aventis SA: key facts 34
Table 16: Sanofi-Aventis SA: key financials ($) 35
Table 17: Sanofi-Aventis SA: key financials (') 35
Table 18: Sanofi-Aventis SA: key financial ratios 36
Table 19: Belgium generics market value forecast: $ million, 2009'14 38
Table 20: Belgium generics market volume forecast: volume penetration, 2009'14 39
Table 21: Belgium size of population (million), 2005'09 40
Table 22: Belgium gdp (constant 2000 prices, $ billion), 2005'09 40
Table 23: Belgium gdp (current prices, $ billion), 2005'09 40
Table 24: Belgium inflation, 2005'09 41
Table 25: Belgium consumer price index (absolute), 2005'09 41
Table 26: Belgium exchange rate, 2005'09 41
LIST OF FIGURES
Figure 1: Belgium generics market value: $ million, 2005'09 10
Figure 2: Belgium generics market volume: volume penetration, 2005'09 11
Figure 3: Belgium generics market segmentation II: % share, by value, 2009 12
Figure 4: Forces driving competition in the generics market in Belgium, 2009 13
Figure 5: Drivers of buyer power in the generics market in Belgium, 2009 15
Figure 6: Drivers of supplier power in the generics market in Belgium, 2009 16
Figure 7: Factors influencing the likelihood of new entrants in the generics market in Belgium, 2009 17
Figure 8: Factors influencing the threat of substitutes in the generics market in Belgium, 2009 19
Figure 9: Drivers of degree of rivalry in the generics market in Belgium, 2009 20
Figure 10: Bayer AG: revenues & profitability 25
Figure 11: Bayer AG: assets & liabilities 25
Figure 12: Novartis AG: revenues & profitability 28
Figure 13: Novartis AG: assets & liabilities 29
Figure 14: Omega Pharma NV: revenues & profitability 33
Figure 15: Omega Pharma NV: assets & liabilities 33
Figure 16: Sanofi-Aventis SA: revenues & profitability 36
Figure 17: Sanofi-Aventis SA: assets & liabilities 37
Figure 18: Belgium generics market value forecast: $ million, 2009'14 38
Figure 19: Belgium generics market volume forecast: volume penetration, 2009'14 39
Generics in Belgium Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Generics in Belgium Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Generics in Belgium
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 250.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Generics in Belgium Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Generics in Belgium Page 6/6